Clinical Trial Update: Early Onset Alzheimer's Disease Genomic Study

View source ↗

Summary

A genomic study focused on early-onset Alzheimer’s disease has completed. The sponsor is Baylor Research Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Baylor Research Institute | Conditions: Alzheimer Disease | Status: COMPLETED